Holen Sie sich die Stockscreener-App
1.29
15.13%
-0.23
Handel nachbörslich:
1.28
-0.01
-0.78%
Schlusskurs vom Vortag:
$1.52
Offen:
$1.23
24-Stunden-Volumen:
7.51M
Relative Volume:
10.57
Marktkapitalisierung:
$157.61M
Einnahmen:
$447.48M
Nettoeinkommen (Verlust:
$-14.55M
KGV:
-8.60
EPS:
-0.15
Netto-Cashflow:
$7.61M
1W Leistung:
-15.69%
1M Leistung:
-0.77%
6M Leistung:
-35.82%
1J Leistung:
-28.73%
1-Tages-Spanne:
$1.1401
$1.30
1-Wochen-Bereich:
$1.1401
$1.60
52-Wochen-Spanne:
$1.1401
$2.95
Accuray Inc Stock (ARAY) Company Profile
Firmenname
Accuray Inc
Sektor
Branche
Telefon
608-824-2800
Adresse
1240 DEMING WAY, MADISON, CA
Vergleichen Sie ARAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
1.29 | 157.61M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-13 | Eingeleitet | ROTH MKM | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Loop Capital | Buy |
| 2020-01-21 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-11-01 | Hochstufung | Citigroup | Sell → Neutral |
| 2017-12-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-11-30 | Eingeleitet | Lake Street | Buy |
| 2016-12-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-12-22 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2015-11-12 | Eingeleitet | Citigroup | Sell |
| 2015-05-01 | Bestätigt | Dougherty & Company | Buy |
| 2015-01-12 | Eingeleitet | Northland Capital | Outperform |
| 2014-01-31 | Bestätigt | Dougherty & Company | Buy |
| 2014-01-29 | Bestätigt | Brean Capital | Buy |
| 2013-11-11 | Bestätigt | Dougherty & Company | Buy |
| 2013-08-29 | Bestätigt | Dougherty & Company | Buy |
| 2011-09-20 | Bestätigt | Ticonderoga | Buy |
| 2010-02-08 | Hochstufung | Jefferies & Co | Hold → Buy |
| 2009-12-09 | Hochstufung | UBS | Sell → Neutral |
| 2009-03-09 | Herabstufung | Soleil | Buy → Hold |
| 2009-01-30 | Hochstufung | Piper Jaffray | Neutral → Buy |
| 2008-12-22 | Bestätigt | Jefferies & Co | Hold |
| 2008-08-20 | Bestätigt | Jefferies & Co | Hold |
Alle ansehen
Accuray Inc Aktie (ARAY) Neueste Nachrichten
Accuray (ARAY) Stock Receives Adjusted Price Target Amid Debt Restructuring | ARAY Stock News - GuruFocus
Accuray stock tumbles on debt exchange concerns - Investing.com Australia
Accuray to Exchange $82 million Worth of Convertible Notes, Gets New Credit Facilities - marketscreener.com
Accuray (ARAY) Announces Debt Exchange and New Credit Facility - GuruFocus
Accuray Incorporated Appoints Steven F. Mayer to Its Board - marketscreener.com
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities | ARAY Stock News - GuruFocus
Accuray announces debt restructuring and board appointment By Investing.com - Investing.com Canada
Accuray Announces Convertible Notes Exchange And Refinancing Of Existing Credit Facilities - marketscreener.com
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities - PR Newswire
ProShare Advisors LLC Buys 9,187 Shares of Accuray Incorporated (NASDAQ:ARAY) - Defense World
Radiation Oncology Treatment Planning Software Market - openPR.com
Wall Street Zen Upgrades Accuray (NASDAQ:ARAY) to Buy - Defense World
Why Is Accuray (ARAY) Up 17% Since Last Earnings Report? - Yahoo Finance
Accuray to Participate in the Jefferies Global Healthcare Conference 2025 - Lelezard
Accuray to Participate in the Jefferies Global Healthcare Conference 2025 | ARAY Stock News - GuruFocus
Image-Guided Radiation Therapy Market Report 2025=2032 - openPR.com
Northern Trust Corp Increases Stock Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Medical Devices Market Is Booming So Rapidly | Fresenius, Johnson & Johnson, Accuray - newstrail.com
Cyber Knife Market : Unlocking Global Growth Opportunities (2025-2032) |Accuray Incorporated, BrainLab, Elekta AB - openPR.com
Accuray (NASDAQ:ARAY) Downgraded by StockNews.com to Hold - Defense World
Accuray Loses CFO; Hires New Executive from Conceptus - Medical Product Outsourcing
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now - MSN
Dimensional Fund Advisors LP Lowers Stock Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
StockNews.com Upgrades Accuray (NASDAQ:ARAY) to Buy - Defense World
Global Lung Cancer Surgery Market Size in 2025 | Most Leading - openPR.com
Barclays PLC Has $449,000 Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Third Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Accuray Presents New Data Showing Benefits Of Robotic Radiotherapy Device CyberKnife At ESTRO - Nasdaq
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 | ARAY Stock News - GuruFocus
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 - PR Newswire
Accuray (NASDAQ:ARAY) Lowered to Hold Rating by StockNews.com - Defense World
ARAY: Accuray's CyberKnife System Debuts in Austria | ARAY Stock News - GuruFocus
Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System - PR Newswire
Equities Analysts Offer Predictions for Accuray Q4 Earnings - Defense World
Revolutionary CyberKnife Cancer Treatment Launches in Austria: Cuts Patient Treatment Time from 40 to 5 Sessions - Stock Titan
Accuray Incorporated (NASDAQ:ARAY) Shares Bought by Wells Fargo & Company MN - Defense World
Roth Capital Predicts Accuray’s Q1 Earnings (NASDAQ:ARAY) - Defense World
Roth Capital Estimates Accuray’s Q1 Earnings (NASDAQ:ARAY) - The AM Reporter
Accuray: Tariffs Are The Latest Obstacle For A Company That Has Struggled To Deliver (Rating Downgrade) - Seeking Alpha
ACCURAY INC SEC 10-Q Report - TradingView
Accuray Incorporated (NASDAQ:ARAY) Q3 2025 Earnings Call Transcript - Insider Monkey
Accuray Incorporated (NASDAQ:ARAY) Delivered A Weaker ROE Than Its Industry - Yahoo Finance
Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care | Libero Quotidiano.it - Libero Quotidiano
ARAY’s Market Whiplash: -29.80% YTD Decline, -21.91% Plunge in 30 Days - investchronicle.com
Should investors be concerned about ARAY’s high price-to-sales ratio? - uspostnews.com
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y - Barchart.com
Accuray Inc [ARAY] Shares Fall -4.32 % on Wednesday - knoxdaily.com
Ready to Jump After Recent Trade: Accuray Inc (ARAY) - Sete News
Accuray (ARAY) Exceeds Q3 Revenue Expectations with Strong Perfo - GuruFocus
Accuray Reports Fiscal 2025 Third Quarter Financial Results | AR - GuruFocus
JPMorgan Chase & Co. Has $481,000 Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Finanzdaten der Accuray Inc-Aktie (ARAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):